Intratumoural heterogeneity and immune modulation in lung adenocarcinoma of female smokers and never smokers

Timo B. Trefzer, Marc A. Schneider, Katharina Jechow, L Chua, Thomas Muley, H. Winter, Mark Kriegsmann, Michael T. Meister, Roland Eils, Christian ConradbioRxiv 2021 · DOI

TL;DR

This study uses single-nucleus RNA sequencing to dissect the complex cellular landscape and immune interactions within lung adenocarcinoma (LADC) in female smokers and never-smokers. It reveals distinct cellular states within tumors and identifies how smoking influences the tumor microenvironment, offering new avenues for targeted therapies, especially for the growing population of never-smoker LADC patients.

What Problem Does This Paper Address?

Lung cancer remains a leading cause of cancer death globally, and while strongly linked to smoking, a significant portion of cases, particularly in women, occur in never-smokers. Understanding the intricate cellular diversity (heterogeneity) within tumors and how the immune system interacts with these cells is crucial for developing effective treatments. This paper specifically addresses the need to better understand this heterogeneity and immune modulation in LADC, with a particular focus on female never-smokers, a group that is increasingly affected and less understood.

Methods

The researchers employed single-nucleus RNA sequencing (snRNA-Seq) on both tumor and matched normal lung tissue samples from female patients with varying smoking histories. This technique allows for the analysis of gene expression at the individual cell level, providing a high-resolution view of cellular diversity.

Key analytical approaches included:

  • Data Integration: Combining data from multiple samples and patient groups while accounting for technical variations.
  • Cell Type Annotation: Identifying different cell types within the lung tissue and tumors by comparing their gene expression profiles to known markers.
  • Differential Gene Expression Analysis: Identifying genes that are expressed at significantly different levels between groups (e.g., smokers vs. never-smokers, tumor vs. normal tissue).
  • Gene Set Enrichment Analysis: Determining which biological pathways or functions are over-represented in the differentially expressed genes.
  • Ligand-Receptor Interaction Analysis: Inferring how different cell types communicate with each other by identifying pairs of signaling molecules and their receptors.
  • Copy Number Variation (CNV) Inference: Estimating large-scale genomic alterations within tumor cells based on their transcriptomic data.
  • Trajectory Inference: Using computational methods (like pseudotemporal ordering) to reconstruct the developmental pathways of malignant cells within the tumor.
  • Non-negative Matrix Factorization (NMF): A technique used to identify underlying patterns or "signatures" of gene expression within the tumor microenvironment.

Datasets

The study utilized fresh frozen surgical tissue samples from 27 patients, including:

  • 26 tumor samples from lung adenocarcinoma (LADC) patients.
  • 12 matching normal lung tissue samples.

These samples were categorized into four groups based on age (young/elderly) and smoking status (smoker/never-smoker), with a specific emphasis on female patients. The researchers also leveraged a previously published atlas of healthy lung snRNA-Seq data as a reference.

Key Insights and Ideas

  • Smoking's Inflammatory Footprint: Even in normal lung tissue, exposure to tobacco smoke triggers a significant inflammatory response, characterized by increased immune cell infiltration and activation of repair mechanisms. This suggests a pre-existing inflammatory environment in smokers that could influence tumor development.
  • Tumor Microenvironment Remodeling: In LADC, both macrophages and cancer-associated fibroblasts show altered transcriptional programs, indicating they are actively responding to the tumor and contributing to its progression. Smoking appears to exacerbate some of these changes.
  • Malignant Cell Heterogeneity: Within the tumors, the researchers identified eight distinct subpopulations of neoplastic (cancer) cells, highlighting the complex cellular diversity within LADC. This heterogeneity is a key challenge for effective treatment.
  • Differentiated Tumor Cell States: Through trajectory analysis, they inferred that tumor cells differentiate towards two distinct states associated with cancer progression and invasiveness, suggesting a developmental path for malignant cells.
  • Immune Modulation by Proliferating Cells: A population of actively dividing tumor cells exhibits unique immune-modulating signatures that differ between smokers and never-smokers, implying that even proliferating cells play a role in shaping the immune response.
  • Shared Trajectories, Divergent Signatures: While the overall developmental pathways of malignant cells were similar between smokers and never-smokers, specific immune-modulating cell populations showed distinct gene expression profiles based on smoking status, particularly in genes related to inflammation and immune response.

Key Results

  • Cell Type Changes in Smokers: Healthy lung tissue from smokers showed a decrease in ciliated and endothelial cells, and an increase in macrophages, including alveolar macrophages, compared to never-smokers.
  • Tumor Microenvironment Signatures: Two distinct macrophage states with decreased inflammatory gene expression were identified in tumors compared to healthy lung. Two fibroblast populations were also characterized, one with reduced expression of genes in the SLIT/ROBO pathway and another with increased expression of collagens, potentially promoting invasion.
  • Immune Modulating Cells: A subset of malignant cells (Imm_1 cluster) showed differential expression of immune-related genes. Smokers had higher expression of genes like ANXA1 and glycodelin (PAEP), which are involved in immune modulation and have been linked to anti-inflammatory effects and immunosuppression, respectively.
  • Validation of Key Markers: Increased expression of ANXA1 and glycodelin in female smokers was validated using immunohistochemistry.

Limitations and Future Work

  • Inter-patient Heterogeneity: The study acknowledges that substantial inter-patient heterogeneity is a significant challenge in analyzing tumor tissues. This can be influenced by genetic background, epigenetics, comorbidities, and patient history. The authors suggest that larger sample sizes and more refined molecular patient stratification are needed.
  • Computational Refinement: Future computational methods that can exclude patient-specific features without losing biologically relevant signals are recommended for further analysis of malignant cell populations.
  • Bulk Omics Validation: The findings from single-cell transcriptomics could be further tested in larger patient cohorts using bulk omics approaches.
  • Environmental Factors: As smoking prevalence declines, future studies should investigate other environmental and intrinsic factors contributing to inflammation, such as inflammatory diseases like COPD.
  • Therapeutic Implications: The identified distinct cellular states and immune-modulating signatures provide a foundation for designing targeted therapies that consider the complex interplay of disease etiology, intratumoral heterogeneity, and the tumor microenvironment. The study highlights the potential for immunotherapies that target specific immune-modulating cells or pathways.

Summary updated

Abstract

Abstract Lung cancer is still the leading cause of cancer death worldwide despite declining smoking prevalence in industrialised countries. Although lung cancer is highly associated with smoking status, a significant proportion of lung cancer cases develop in patients who never smoked, with an observable bias towards female never smokers. A better understanding of lung cancer heterogeneity and immune system involvement during tumour evolution and progression in never smokers is therefore highly warranted. We employed single nucleus transcriptomics of surgical lung adenocarcinoma (LADC) and normal lung tissue samples from patients with or without smoking history. Immune cells as well as fibroblasts and endothelial cells respond to tobacco smoke exposure by inducing a highly inflammatory state in normal lung tissue. In the presence of LADC, we identified differentially expressed transcriptional programmes in macrophages and cancer-associated fibroblasts, providing insight into how the niche favours tumour progression. Within tumours, we distinguished eight subpopulations of neoplastic cells in female smokers and never smokers. Through pseudotemporal ordering, we inferred a trajectory towards two differentiated tumour cell states implicated in cancer progression and invasiveness. A proliferating cell population sustaining tumour growth exhibits differential immune modulating signatures in both patient groups. Our results resolve cellular heterogeneity and immune interactions in LADC, with a special emphasis on female never smokers and implications for the design of therapeutic approaches.
BibTeX
@misc{trefzer2021intratumoural,
  author = {Timo B. Trefzer and Marc A. Schneider and Katharina Jechow and L Chua and Thomas Muley and H. Winter and Mark Kriegsmann and Michael T. Meister and Roland Eils and Christian Conrad},
  title = {{Intratumoural heterogeneity and immune modulation in lung adenocarcinoma of female smokers and never smokers}},
  year = {2021},
  doi = {10.1101/2021.05.18.444603},
  howpublished = {bioRxiv},
}
Figure